Postnatal growth and metabolic blood biomarkers in preterm infants developing reversible retinopathy of prematurity
Postnatal growth and metabolic blood biomarkers were significantly associated with milder, reversible ROP, but none of these gave prediction over and above GA and SGA. Due to the small sample sizes, potential predictors could only be investigated in univariate analyses. Larger studies are needed to fully explore the predictive potential of all the biomarkers.
Authors
- Dorte Aalund Olsen (ORCID: https://orcid.org/0000-0003-2589-738X)
- Julie Lyng Forman (ORCID: https://orcid.org/0000-0001-7368-0869)
- Aneta Aleksandra Nielsen
- Gorm Greisen (ORCID: https://orcid.org/0000-0001-8042-3262)
- Frederik Sørensen
- Carina Slidsborg (ORCID: https://orcid.org/0000-0002-0404-0726)
- Ivan Brandslund (ORCID: https://orcid.org/0000-0002-4203-5442)
Institutions
- University of Copenhagen (DK)
- University of Southern Denmark (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Vejle Sygehus (DK)
- Region of Southern Denmark (DK)
- IT University of Copenhagen (DK)
Publication Details
- Journal
- BMJ Open Ophthalmology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjophth-2024-001975
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dagmar Marshalls Fond
- Vissing Fonden
- Synoptik-Fonden
- Aase og Ejnar Danielsens Fond